Fluor Misses Q3 2026 Estimates as Revenue Rises 10% to $3.72B

Fluor (FLR) missed estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $3.72 billion, up 10% from a year earlier, below the $4.16 billion estimate, and adjusted EPS was $0.77, up 13% from a year earlier, below the $0.80 estimate.

Shares rose 2.1% in premarket trading as of 5:57 a.m. ET, to $46.00 from a $45.04 close.

Q3 2026 scorecard

By our calculation, revenue was $444.2 million below the estimate and adjusted EPS was $0.03 below it. The QoQ column compares with the previous quarter's revenue of $4.33 billion and adjusted EPS of $0.91. The YoY column compares with $3.37 billion and $0.68 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 3 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 2 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $3.37 billion, $4.17 billion, $3.66 billion, $4.33 billion and $3.72 billion.

What to watch

• Next-quarter estimates. Consensus calls for EPS of $0.86 and revenue of $4.40 billion next quarter, based on 3 analysts.
• Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 10% increase to $3.72 billion.
• Estimate record. Whether Fluor returns to beating EPS estimates, which it did in 3 of its last 8 reports.
• Related coverage. See our reports on Kyivstar, National HealthCare, Pacira BioSciences and Celldex Therapeutics.

Sources: Results are from Fluor's Nov. 6, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Fluor's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.